Friday, August 21, 2026
GlobeNewsInfo Logo
Legal Department

Terms of Service

The guidelines, rules, and overarching agreements governing your access and usage of GlobeNewsInfo platforms and services.

Terms of Service

Last Updated: August 27, 2026

By accessing or using this website, you agree to comply with and be bound by the following Terms and Conditions. If you do not agree, please refrain from using our services.

1. Use of Content

All content provided on this website is for informational and professional use only. Unauthorized use, reproduction, or distribution is prohibited unless explicitly permitted.

2. No Professional Advice

The information published does not constitute legal, financial, investment, or professional advice. Users should conduct independent verification before making decisions.

3. User Responsibilities

Users agree to:

  • Use the website lawfully
  • Not disrupt or damage the platform
  • Not attempt unauthorized access to systems or data

4. Bulk Content & Licensing

Bulk news content, feeds, APIs, or syndicated materials are subject to separate agreements and licensing terms. Unauthorized redistribution is strictly prohibited.

5. Intellectual Property

All intellectual property rights remain the exclusive property of the website and its licensors.

6. Limitation of Liability

We shall not be liable for:

  • Errors or omissions in content
  • Losses arising from reliance on published information
  • Technical interruptions or service downtime

7. Termination

We reserve the right to suspend or terminate access to users who violate these terms without prior notice.

8. Governing Law

These Terms shall be governed by and interpreted in accordance with applicable laws, without regard to conflict of law principles.

Just In
1 hour ago Skanska secures NOK 320 million healthcare construction project in Norway 2 hours ago Labcorp executes 722 million dollar asset purchase agreement to acquire BioReference diagnostics units from OPKO Health 2 hours ago Mankind Pharma enters oncology cell therapy market with 48 million euro acquisition of Armed Cell Therapeutics 2 hours ago Proofpoint acquires Varonis Systems in 6.3 billion dollar all-cash deal to expand AI security platform